Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In eHealth, Inc. (EHTH) To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in eHealth, Inc. (“eHealth” or the “Company”) (NASDAQ: EHTH) of the March 27, 2015 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against eHealth and certain officers of the Company.
A complaint has been filed in the United States District Court for the Northern District of California on behalf of all persons who purchased eHealth common stock between October 31, 2014 and January 14, 2015 (the “Class Period”).
The complaint alleges that the Company and its executives violated federal securities laws with respect to its statements concerning its business, operations, and prospects.
Specifically, the action alleges that during the Class Period, eHealth issued false and misleading statements regarding the Company’s true financial condition and prospects.
On January 14, 2015, eHealth announced that it was lowering its fiscal 2014 revenue guidance, attributing the revision in part to lower than expected applications for its Individual & Family Plan.
Following this news, the price of the Company’s stock declined by $11.38 per share, or nearly 55%, to close on January 15, 2015 at $9.42 per share.
If you invested in eHealth common stock or options between October 31, 2014 and January 14, 2015 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding eHealth’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.